首页> 外国专利> Inhibitors of Matrix Metalloproteinases pirimidinonas merged based on ref.pca428-01cfp / BB

Inhibitors of Matrix Metalloproteinases pirimidinonas merged based on ref.pca428-01cfp / BB

机译:基于ref.pca428-01cfp / BB合并的基质金属蛋白酶抑制剂pirimidinonas

摘要

Are Selective inhibitors of MMP - 13 pirimidonas merged the formula or a pharmaceutically acceptable Salt thereof; wherein: W, together with the carbon Atoms to which it is connectedDirradical form an annular 5 miembrosx is o, S, so, SO2, NR5, o CH2 - C -, - S - o; b is either well or NR5; or are taken together to form and B - C = C; R1, R4 and R5 is Hydrogen, alkyl,Alquenilo, aquinilo, (CH2) n - (N - (CH2), cycloalkyl, alcanoilo C1 - C6 or N - (CH2) heteroaryl; R2 and R3 is Hydrogen, alkyl, alquenilo, alquinilo, CN, NO2, nr4r5, (CH2) n - (N - (CH2) cycloalkyl, aryl,O (CH2) n - heteroaryl.R2 can be also Halo; n is an integer from 0 to 5, and yr4 R5, when taken together with nitrogen which are United,Complete a Ring member that contains 3 to 8 Carbon Atoms and optionally contains o, s or n,And is replaced or not replaced; with the exception of R1 and R3 are both selected Hydrogen and alkyl of C1 - C6.
机译:是MMP-13吡虫酰胺的选择性抑制剂与该配方或其药学上可接受的盐合并;其中:W与与之连接的碳原子一起呈环状地形成一个5环的环状微乳,o为S,所以SO2,NR5为o,CH2-C-,-S-o为O; b是很好或NR5;或合在一起形成B-C = C; R1,R4和R5为氢,烷基,Alquenilo,aquinilo,(CH2)n-(N-(CH2),环烷基,Alcanoilo C1-C6或N-(CH2)杂芳基; R2和R3为氢,烷基,Alquenilo, R2也可以是Halo; n是0到5的整数,而yr4 R5是,当与被结合的氮一起使用时,完成一个包含3至8个碳原子并可选地包含o,s或n的环成员,并且被取代或不被取代; R1和R3均被选择为氢和烷基C1-C6。

著录项

  • 公开/公告号SV2003000882A

    专利类型

  • 公开/公告日2003-01-13

    原文格式PDF

  • 申请/专利权人 WARNER-LAMBERT COMPANY;

    申请/专利号SV20020000882

  • 发明设计人

    申请日2002-02-13

  • 分类号C07D491/048;A61K31/519;A61K31/5377;A61P9;A61P9/04;A61P9/10;A61P19/02;A61P19/10;A61P25;A61P29;A61P35;A61P43;C07D487/04;C07D491/04;C07D495/04;

  • 国家 SV

  • 入库时间 2022-08-22 00:01:10

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号